You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 11, November 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Outcome and Complications of Extended Cranial-Base Resection Requiring Microvascular Free-Tissue Transfer

Gary L. Clayman, DDS, MD; Franco DeMonte, MD, FRCSC; Debra M. Jaffe, MD; Mark A. Schusterman, MD; Randal S. Weber, MD; Michael J. Miller, MD; Helmuth Goepfert, MD

Arch Otolaryngol Head Neck Surg. 1995;121(11):1253-1257.


Abstract

Objectives
To determine the complications of extensive cranial-base resection requiring free-tissue transfer (FTT) and the effect of these resections on local control and survival among patients with malignant neoplasms of the skull base.

Background
Before the advent of FTT, cranial-base surgery was often limited by our inability to adequately repair defects comprising communication between the central nervous system and upper aerodigestive tract. The use of FTT in cranial-base resections was therefore assessed to determine whether the improved procedure (ie, extensive resections) would improve local control and prolong survival.

Design
A retrospective review of 39 consecutive craniofacial resections with FTT reconstruction in patients with malignant neoplasms involving the cranial base.

Patients
All 39 patients had malignant neoplasms, including 20 squamous cell carcinomas, eight basal cell carcinomas, two melanomas, two neuroendocrine carcinomas, two adenoid cystic carcinomas, and various other malignant neoplasms. Resections involved the anterior, middle, or posterior cranial fossa in 19 patients (49%), 10 patients (26%), and three patients (8%) of cases, respectively. The remaining seven surgeries (18%) involved resection of more than one of these cranial base sites.

Results
Early (<14 days after surgery) complications occurred in 14 (36%) of 39 patients. Major complications included failure of microvascular anastomosis (n=1), pneumonitis (n=3), perioperative myocardial infarction (n=1), and cerebrovascular accident (n=1). The microvascular anastomosis failure was promptly treated with surgical intervention. Two patients (5%) experienced late postoperative complications; one had cellulitis at the donor site, and the other had pneumonitis. No perioperative deaths or complications such as meningitis, epidural abscess, or tension pneumocephalus occurred. The 2-year disease-specific survival rate was 55%, and the 2-year local control rate, 49%; both were determined by the Kaplan-Meier method. The nine patients who died of their disease had a median survival of 9 months. Logrank testing showed that pathologically positive margins and transdural pathology were the most significant predictors of local recurrence and death of disease.

Conclusions
Contemporary surgical approaches provide an opportunity for wide surgical excision of dura and skull-base structures that normally separate the intracranial and extracranial cavities. These major skull-base resections can be reconstructed safely and effectively with FTT. Patients with malignant neoplasms of the dura and skull base should be approached with the understanding that transdural disease portends an increased risk of local recurrence and death of disease.

(Arch Otolaryngol Head Neck Surg. 1995;121:1253-1257)



Author Affiliations

From the Departments of Head and Neck Surgery (Drs Clayman, Jaffe, Weber, and Goepfert), Neurosurgery (Dr DeMonte), and Reconstructive and Plastic Surgery (Drs Schusterman and Miller), The University of Texas M. D. Anderson Cancer Center, Houston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atypical Facial Access: An Unusually High Prevalence of Use Among Patients With Skull Base Tumors Treated at 2 Centers
Cernea et al.
Arch Otolaryngol Head Neck Surg 2007;133:816-819.
ABSTRACT | FULL TEXT  

Microvascular reconstruction of cranial base defects: An evaluation of complication and survival rates to justify the use of this repair.
Newman et al.
Arch Otolaryngol Head Neck Surg 2006;132:381-384.
ABSTRACT | FULL TEXT  

Craniofacial Resection for Malignant Tumors Involving the Anterior Skull Base
Shah et al.
Arch Otolaryngol Head Neck Surg 1997;123:1312-1317.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.